FDA has released the Guidance on Conduct of Clinical Trials of Medical Products during the COVID-19 pandemic

March 19, 2020

FDA has released the Guidance on Conduct of Clinical Trials of Medical Products during the COVID-19 pandemic

Yesterday morning FDA has released the Guidance on Conduct of Clinical Trials of Medical Products during the COVID-19 pandemic.

Here are the parts of Guideline recommendations that may be successfully followed with Flex Databases system:

Protocol deviations and IRBs/IEC submissions tracking

The Guideline states, that “FDA recognizes that protocol modifications may be required and that there may be unavoidable protocol deviations due to COVID-19 illness and/or COVID-19 control measures.”  In CRA Activity Management module, Flex Databases has inbuilt protocol deviations tracking – so a user can easily track all occurring deviation and make further reporting much more comfortable.

It also mentions that “Sponsors and clinical investigators are encouraged to engage with IRBs/IEC as early as possible when urgent or emergent changes to the protocol or informed consent are anticipated as a result of COVID-19.” Investigators & Sites Management module provides centralized ethic committees submissions and approval tracking to speed-up communications between both sides of the process.

Study data integrity

Several times FDA mentions the importance of trial integrity. The Guideline states, that “Efforts to minimize impacts on trial integrity, and to document the reasons for protocol deviations, will be important.” Flex Databases system is equipped with a full audit trail to ensure that no data is ever lost. Any activity inside of the system is reported precisely on Who does What, When, and Why.

Changes in policies and procedures

The Guideline says, that “Sponsors, clinical investigators, and IRBs should consider establishing and implementing policy and procedures, or revise existing policy and procedures, to describe approaches to be used to protect trial participants and manage study conduct during possible disruption of the study as a result of COVID-19 control measures at study sites.“

With Flex Databases system, our clients can optimize and automate the following:

  • study visits and procedures
  • study monitoring
  • adverse event reporting
  • changes in investigator(s), site staff, and/or monitor(s) secondary
  • and many more aspects of clinical trial management.

Flex Databases system ensures full business continuity, regulatory compliance, and data integrity, which importance is clearly stated in the Guideline. We are ready to provide any additional support and answer any questions to make a difficult period we are passing through to go as smoothly as it is ever possible. The level of service and system uptime will not be affected during the time of the crisis.

We carefully follow all changes in relevant regulations both on global and local levels and design system updates in compliance with the actual situation in the industry.

If you have any questions regarding Flex Databases compliance with the new FDA Guideline or any other needs, do not hesitate to contact us via contact@flexdatabases.com.

Stay at home,

Flex Databases

Blog

February 6, 2025
Palobiofarma Chooses Flex Databases for Pharmacovigilance Management 

Palobiofarma is a leading clinical-stage biotech company dedicated to developing innovative medicines. Our focus on adenosine signaling drives our commitment to scientific excellence, with six drug candidates currently in different phases of development. Among them, PBF-999 for Prader-Willi Syndrome stands out as a key project. Our mission is to advance patient care by leveraging cutting-edge […]

February 4, 2025
Enhancing TMF Efficiency with the New Duplicates Search Feature

At Flex Databases, we continuously improve our Trial Master File system to enhance compliance, efficiency, and user experience. Our latest update introduces an advanced Duplicates Search Feature, streamlining document management and ensuring data integrity. Introducing the Duplicates Search Feature The Duplicates Search Feature helps users identify and manage duplicate files within the TMF. It prevents […]

January 30, 2025
Streamlined Document Management with Linked Files

To simplify this process of documents efficiently management across multiple clinical projects Flex Databases introduces the Linked File feature, a powerful solution that centralizes document storage, streamlines updates, and enhances compliance. Key Features Flex Databases’ Linked Files feature centralizes key documents, connecting them to multiple projects. This eliminates the problems of managing document copies. It […]

January 23, 2025
Flex Databases at EUCROF 2025

We are thrilled to announce that Flex Databases is a proud sponsor of EUCROF 2025, taking place from February 2-4, 2025! Our team members, Tamara Prekodravac and Evgenia Michalchuk-Vrablik, will represent us at this prestigious event, where industry leaders come together to drive innovation and collaboration in clinical research. This year’s event will cover important […]

Contact us

Get in touch to discuss compliance, implementation, demos, pricing

We are here for all of your questions! Tell us more about yourself and we will organize a tailored live demo to show how you can power up your clinical trials processes with Flex Databases.